Silence Therapeutics SLN
NASDAQ SLN
$19.67 +0.01 (+0.05%)
At close: Oct 23, 2026 · 4:00 PM EDT

Silence Therapeutics (SLN) Net Shares Issued and Repurchased (2024 - 2026)

Updated

Analysis

Silence Therapeutics (SLN) Net Shares Issued and Repurchased (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn -1.60 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn -966.00 Mn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn -9.00 Mn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -714.00 Mn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn -1.20 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 6.00 Mn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -346.00 Mn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn -
10 Silence Therapeutics 929.38 Mn 857.28 Mn - 2,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2,000.00
Jun 30, 2025 1,000.00
Mar 31, 2025 14,000.00
Dec 31, 2024 -98,000.00
Sep 30, 2024 7.97 Mn
Jun 30, 2024 1.19 Mn
Mar 31, 2024 133.02 Mn
API Access

Silence Therapeutics Net Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-shares-issued-and-repurchased&ticker=SLN&period=max&api_key=YOUR_API_KEY